Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Neurobiology has improved the integrative understanding of brain development. With digital technologies, digital (bio)markers would be relevant variables for a better understanding of the heterogeneity of cognitive and behavioral functioning in developing children.
However, the dominant statistical approach of group comparison tends to ignore intragroup variability. Applying high-dimensional data sets through multivariate methods and then combining their scores via predictive model learning algorithms would allow the identification of subtypes. Thus, EPIDIA4KIDS wants to understand the brain functioning of children aged 7 to 12 years old from heterogeneous data sources collected from a touchscreen tablet.
Full description
The overall objective of the EPIDIA4KIDS study is to understand brain functioning in children aged 7 to 12 years from heterogeneous digital data collected with a touch tablet. The investigators want to develop a digital e-screening, similarly to a blood test result, for cognitive, emotional and behavioral performances in children from 7 to 12 years old, resulting from a multimodal and multi-stream analysis generated by an artificial intelligence algorithm.
The main aims are therefore to:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
No biological parent or legal guardian is able to give permission for the minor and agrees to participate in parental assessments
Prematurity or other perinatal complications that required significant intervention
History of neurological disorders, including seizure disorders, cerebral palsy, or other conditions requiring neurological or medical care :
History of head injury:
Current use of medications with significant effects on brain function or blood flow (e.g., antipsychotics, mood stabilizers); Attention Deficit Hyperactivity Disorder (ADHD) medications and Selective Serotonin Reuptake Inhibitors (SSRIs) are not excluded as the use of these medications is associated with certain neurodevelopmental disorders and assessment of these individuals will provide useful data to the community Not fluent in French (all youth materials are in French) Uncorrectable visual, hearing, or sensorimotor impairment, as the protocol items may not be valid.
Primary purpose
Allocation
Interventional model
Masking
736 participants in 1 patient group
Loading...
Central trial contact
Vanessa Douet Vannucci, PhD; Théo Marchand, Msc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal